Breeze Meds GLP-1 Review
By Iacob Pastina · Updated
Is Breeze Meds right for you?
The no-subscription model is BreezeMeds' main selling point: month-by-month ordering with no billing commitments, which suits patients burned by hard-to-cancel subscriptions elsewhere, and four GLP-1 formulations add real choice.
Plans & pricing
Injectable Semaglutide
Listed price
$199
Per-order compounded semaglutide injection, no subscription required
We may earn a commission. Our review stays independent.
Check this plan’s pricing details Compare the complete price schedule →Consider it if
Patients who don't want subscription commitments and prefer ordering month-by-month, or who want oral dissolving tablet options.
Consider alternatives if
Anyone who wants to read the contract before paying. BreezeMeds publishes no terms of service, and its FAQ never answers what shipping costs or whether insurance is accepted.
Compare alternatives →Independent research, not medical advice. See our sources and safety checks.
All plans, payment and cancellation terms
- Consultation
- Included
- Shipping
- Free
- Insurance
- Not accepted
- Availability
- All 50 states, per the site's FAQ
Cancellation and refunds: No subscription required, order on demand
Want the standalone record? Breeze Meds pricing, every tier with verification dates and detected promotions.
All pricing tiers
Injectable Semaglutide
$199 View details ↗Per-order compounded semaglutide injection, no subscription required
Injectable Tirzepatide
$399 View details ↗Per-order compounded tirzepatide injection, listed on the homepage at $399 a month, one injection per week
Oral Semaglutide
$299 View details ↗Per-order compounded oral dissolving semaglutide tablet
Oral Tirzepatide
$399 View details ↗Per-order compounded oral dissolving tirzepatide tablet
Why we reached this verdict
BreezeMeds' no-subscription model is a genuine differentiator: you order when you need medication, with zero recurring billing. Four GLP-1 formulations (injectable semaglutide at $199, injectable tirzepatide at $399, oral semaglutide at $299, oral tirzepatide at $399) plus FSA/HSA eligibility add flexibility, and the company names its Marietta, GA address, its medical group and four partner pharmacies. What it does not publish is a terms of service, and the FAQ answers on cost, insurance and shipping are attached to the wrong questions, so at $199 to $399 a month you are buying before you can read the contract. The per-order model at least caps your exposure to a single month while you check.
What makes it different: No subscription required, pay per order rather than committing to recurring billing, with four GLP-1 formulations including oral dissolving tablets.
Breeze Meds Pros and Cons
What We Like
What We Like
- +No subscription required, order on demand without recurring billing commitments
- +Four GLP-1 formulations: injectable semaglutide, injectable tirzepatide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
What Could Be Better
What Could Be Better
- −No terms of service is published anywhere on the site, even though the privacy policy says your use of the platform is governed by one. The FAQ questions about cost, insurance and shipping are answered with unrelated text, so shipping cost and insurance acceptance are never actually stated (checked 2026-09-03).
- −Only the semaglutide injection sits at the $199 floor. Oral semaglutide starts at $299 and both tirzepatide options, tablet and injection, start at $399 on the homepage pricing grid, so a tablet only costs extra if you want semaglutide.
- −The medical team named on the site, Lion MD led by Dr. Ana Lisa Carr and Dr. Kelly Tenbrink, is the same clinical leadership named by CareBareRX, so shopping the two against each other does not get you a second independent option.
Is Breeze Meds legit? Pharmacy, prescribers and safety checks
Six trust signals, how we checked them, and what's been updated since the last review.
Clinical evidence: 20.9% average body-weight reduction at 72 weeks in SURMOUNT-1 (NEJM, 2022). Individual results vary; compounded GLP-1s are not FDA-approved.
What the doctors say about GLP-1 medications
Independent, sourced clinical context on the medication class, not a comment on this provider.
“We now have medicines that not only reduce heart attacks, strokes, and peripheral arterial disease, but also simultaneously lead to meaningful weight loss, which in turn lowers the risk of many weight-related conditions. These treatments also improve patients' quality of life in a meaningful way, making this a genuine win, win.”
“It's the first time that we have seen this magnitude of weight loss compared to current medications on the market for obesity. It's 1.5 to 2.5 times more effective than currently available drugs.”
Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.
How Breeze Meds works
Complete Online Medical Visit
Answer questions about your health history, current medications, and weight loss goals.
Provider Evaluation
A licensed healthcare provider evaluates your information and determines if GLP-1 therapy is appropriate.
Order Ships, No Subscription
If approved, medication ships with discreet packaging. No recurring subscription, reorder when you need more.
Medications available
Ready to check Breeze Meds's pricing for yourself?
Visit Breeze MedsCommon questions
Do I need a subscription?+
Are oral tablet options available?+
Are the medications FDA-approved?+
More questions (2)
Can I cancel Breeze Meds, and what are the terms?+
Does Breeze Meds take insurance?+
Alternatives to Breeze Meds
Similar providers by type, price, and features
More comparisons for Breeze Meds
People also compare Breeze Meds
Helpful tools and related reading
FDA Proposes 503B Bulk-Compounding Exclusions for Semaglutide, Tirzepatide & Liraglutide
Side Effects & SafetyHow to Manage GLP-1 Side Effects: A Practical Symptom Checklist
News & PipelineRetatrutide TRIUMPH-1 Results (May 2026): 30.3% Weight Loss, Phase 3 Primary Trial
Helpful Tools
Ready to get started with Breeze Meds?
Headline offer: from $199/mo. See if you qualify today.
Visit Breeze Meds